Chiara Paolini

Via Tronto 10/A
Ancona, 60126, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Micro- and Macro-Vascular Disease in Systemic Sclerosis and Very Early SSc (VEDOSS): Results from a Monocentric Observational Study.

Micro- and Macro-Vascular Disease in Systemic Sclerosis and Very Early SSc (VEDOSS): Results from a Monocentric Observational Study.

Journal: Biomedicines

Published: February 02, 2026

Exploring potential VEGF receptor 2 inhibitors: a molecular modeling and pharmacophore-based screening approach.

Exploring potential VEGF receptor 2 inhibitors: a molecular modeling and pharmacophore-based screening approach.

Journal: Scientific reports

Published: December 09, 2025

Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine.

Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine.

Journal: International journal of molecular sciences

Published: July 13, 2023

Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study.

Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study.

Journal: International journal of molecular sciences

Published: February 28, 2023

Adeno-Associated Virus Type 5 Infection via PDGFRα Is Associated With Interstitial Lung Disease in Systemic Sclerosis and Generates Composite Peptides and Epitopes Recognized by the Agonistic Immunoglobulins Present in Patients With Systemic Sclerosis.

Adeno-Associated Virus Type 5 Infection via PDGFRα Is Associated With Interstitial Lung Disease in Systemic Sclerosis and Generates Composite Peptides and Epitopes Recognized by the Agonistic Immunoglobulins Present in Patients With Systemic Sclerosis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: February 06, 2023

Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis.

Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis.

Journal: Frontiers in immunology

Published: October 17, 2022

PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis.

PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis.

Journal: International journal of molecular sciences

Published: February 28, 2022

Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches.

Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches.

Journal: Biomedicines

Published: November 25, 2021

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin.

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin.

Journal: Journal of visualized experiments : JoVE

Published: May 21, 2019

Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice.

Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice.

Journal: PloS one

Published: September 29, 2017

Corrigendum: Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro.

Corrigendum: Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro.

Journal: Frontiers in immunology

Published: March 07, 2017

Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach.

Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach.

Journal: Analytical biochemistry

Published: December 15, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026